Becker E, Dedden M, Gall C, Wiendl M, et al. Residual homing of alpha4beta7-expressing beta1(+)PI16(+) regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab. Gut 2022;71:1551-1566.
PMID: 34462337